Join Drs Catenacci and Uboha for an expert discussion on the role of immunotherapy in gastric/GEJ cancers.

The goal of this activity is to inform clinicians about the current indications and guideline recommendations for immunotherapy in gastric/gastroesophageal junction cancers, and discuss ongoing clinical trials.

This activity is intended for oncologists, gastroenterologists, and pathologists.

Learning Objectives:

• Have increased knowledge regarding the
  • Immunotherapy-based treatment in the management of gastric/GEJ cancers
• Have greater competence related to
  • Identifying patients for immunotherapy-based treatment in the appropriate clinical setting reflective of biomarkers and previous treatments

Approximate Time to Complete: 30 minutes

Credit Available: April 5, 2021 - April 5, 2022

Developed through a partnership between SITC and Medscape.

Additional Resources for Clinicans from SITC: